Technical Name Novel Lutein Formulation Development for Dry Eye Syndrome Treatment
Project Operator Taipei Medical University
Project Host 曾靖孋
Summary
The dry eye syndrome (DES) market will reach to 4.9 billion US$ in 2024! An effective medication for treating DES is demanded! Lutein is a common ingredient in healthy food, people take lutein tablets to keep vision function. However, oral administration of lutein in monkeys revealed high lutein amount accumulated in heart, liver, and kidneys; very low lutein content was detected in eye. Long-term taking lutein is a risk to cause liver/kidneys damages. A novel lutein eye drop is developed to instead the oral way for eye treatment especially in DES. Lutein was tested in human corneal epithelium cells (HCECs), low concentration of lutein was nontoxicity to HCECs, and it can retain on the eyes for longer time. The results indicated lutein can decreased the inflammation gene (IL1b, IL6, and TNFa) expression in cells and DES mice. The DES mice treated by lutein eye drop showed damaged corneal recovery, tear amount increasement, and inflammatory relief, it’s a new choice for DES in clinics
Scientific Breakthrough
- A novel lutein eye drops, not oral taking, for eye delivery was developed.
-This the first lutein formula for dry eye treatment, not restricted in retina/macular protection.
-By the formula design, additive selection, this lutein eye drops can enhanc
Industrial Applicability
The major DES drug is RESTASIS®, its component is cyclosporine usually cause eye burning/itching in patients! The working mechanism of lutein for treating DES is different from those drugs, it's the potential for lutein eye drops for DES. Lutein as healthy food for vision protection, the daily intake must reach ~50 mg, high amount of lutein needed rising the production cost, and  high accumulation in liver/kidney by oral way. This lutein eye drops can have therapeutic effect in inhibiting inflammation on ocular surface, promoting corneal healing, and increasing the secretion of tears for DES treatment just in microgram of lutein. Low lutein content but high therapeutic effect in this lutein formula leads to less lutein need for production as a cost saving way for a business development.
Keyword Lutein eye drop dry eye syndrome tear secretion anti-inflammation bioavailability corneal wound healing viscosity osmolarity slow release
Notes
  • Contact
other people also saw